Work

MR Imaging Biomarkers in Oncology Clinical Trials

Year: 2015

Type: article

Source: Magnetic Resonance Imaging Clinics of North America

DOI: 10.1016/j.mric.2015.08.002

Authors: Richard G. Abramson, Lori R. Arlinghaus, Adrienne N. Dula, C. Chad Quarles, Ashley M. Stokes, Jared A. Weis, Jennifer G. Whisenant, Eduard Y. Chekmenev, Igor Zhukov, Jason M. Williams, Thomas E. Yankeelov

Institutions: Vanderbilt University, National Research Nuclear University MEPhI

Language: English

Topic: MRI in cancer diagnosis

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Science Foundation, U.S. Department of Defense, Association of University Radiologists, National Institutes of Health, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Center for Research Resources, National Center for Advancing Translational Sciences, Congressionally Directed Medical Research Programs

Awards: G1050785286, Screening and Monitoring Response to Treatment Using Subsecond Molecular Imaging and Hyperpolarized Contrast Agents, G1392667886, G1815062656, Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy, G196227769, International Collaboration in Chemistry: Collaborative Research: Development of Novel Catalysts and Approaches for Parahydrogen-Induced Enhancement of Magnetic Resonance, G2226317914, G2518858141, G292747457, G304498758, G3089177148, MRI Assessment of Tumor Perfusion, Permeability and Cellularity, G4267969883, G4955926212, The Vanderbilt Institute for Clinical and Translational Research (VICTR) KL2, G723443375, G9000073449, G946978917

OpenAlex ID: W2175635367

FWCI: 3.5

Cites: 162

Cited by: 47

Related to: 10